D.T.R.G Study Highlighted in the News
This week, the results of the REGENT-1 trial, sponsored by Endogenex, was highlighted by both The Herald Sun and 9 News.
The REGENT-1 trial was a first in human clinical trial of the new endoscopic ReCET procedure, aimed at improving glucose control in individuals with type 2 diabetes.
The results of the the trial demonstrated that participants experienced a substantial improvement in blood glucose control over the 12 month period following the procedure. Some participants were also able to reduce the number of diabetes medications they were prescribed, as well as reducing their cholesterol, triglycerides, and weight, and improve their overall quality of life.
D.T.R.G are exceptionally proud of the results of this study, which are being presented at the American Diabetes Association’s 2025 annual conference in Chicago this week.
Investigation of this procedure is ongoing in the ReCET Study, which is currently recruiting participants. More information about the procedure and expression of interest in the study can be found here.
D.T.R.G Study Highlighted in the News
This week, the results of the REGENT-1 trial, sponsored by Endogenex, was highlighted by both The Herald Sun and 9 News.
The REGENT-1 trial was a first in human clinical trial of the new endoscopic ReCET procedure, aimed at improving glucose control in individuals with type 2 diabetes.
The results of the the trial demonstrated that participants experienced a substantial improvement in blood glucose control over the 12 month period following the procedure. Some participants were also able to reduce the number of diabetes medications they were prescribed, as well as reducing their cholesterol, triglycerides, and weight, and improve their overall quality of life.
D.T.R.G are exceptionally proud of the results of this study, which are being presented at the American Diabetes Association’s 2025 annual conference in Chicago this week.
Investigation of this procedure is ongoing in the ReCET Study, which is currently recruiting participants. More information about the procedure and expression of interest in the study can be found here.